News | March 07, 2011

Occlutech Wins Swedish Court Ruling Against AGA-St. Jude Medical

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent litigation case with AGA Medical-St. Jude Medical.

In the ruling by Stockholm’s Tingsratt , the district court of Stockholm, the court does not see any basis for AGA-St Jude's claim that the Occlutech atrial septal defect (ASD) and patent foramen ovale (PFO) occluders violate any patent brought forward in the litigation. The Stockholm court decision is similar to the first instance ruling in the United Kingdom, which was confirmed by the appeal court in the United Kingdom, the last one received mid-2010. The U.K. ruling is final as the U.K. supreme court did not allow an appeal requested by AGA. The favorable Stockholm ruling is also similar to first instance as well as appeal court decisions in The Hague, in the Netherlands, the last one obtained in the end of 2010.

The rulings in Sweden and The Netherlands are subject to appeal by AGA-St. Jude Medical.

Throughout the litigation, Occlutech's owners and investors have funded work in maintaining and substantially strengthening Occlutech's own patent position. In 2011 and 2012, Occlutech expects to launch additional occluders for indications such as patent ductus arteriosus (PDA) and ventricular septal defect (VSD) in addition to second generation ASD and PFO occluders. Also, an innovative left atrial appendage (LAA) occluder, a new generation of stent grafts and cardiac valve intervention technologies are being developed.

For more information: www.occlutech.com

Related Content

Gore Cardioform ASD Occluder Receives FDA Approval
Technology | Structural Heart Occluders | June 10, 2019
W. L. Gore & Associates (Gore) announced the U.S. Food and Drug Administration’s (FDA’s) premarket approval (PMA)...
Le Bonheur Children's Hospital Implants First Abbott Amplatzer Piccolo Occluder
News | Structural Heart Occluders | February 13, 2019
Le Bonheur Children's Hospital cardiologists in Memphis, Tenn., implanted the Amplatzer Piccolo Occluder, the world's...
FDA Approves Abbott's Amplatzer Piccolo Occluder
News | Structural Heart Occluders | January 16, 2019
Abbott announced the U.S. Food and Drug Administration (FDA) approved the Amplatzer Piccolo Occluder to treat patent...
FDA Approves Gore Cardioform Septal Occluder for PFO Closure Prevent Recurrent Ischemic Stroke
Technology | Structural Heart Occluders | April 03, 2018
April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen oval
University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-...